NCT00234195View on ClinicalTrials.gov

Wellbutrin XL, Major Depressive Disorder and Breast Cancer

PHASE4CompletedINTERVENTIONAL

Enrollment

25

Participants

Timeline

Start Date

September 30, 2005

Study Completion Date

January 31, 2007

Conditions

Breast CancerMajor Depressive Disorder

Interventions

DRUG

bupropion extended release (Wellbutrin XL)

Trial Locations (1)

19107

Thomas Jefferson University, Department of Psychiatry, Philadelphia

Sponsors

Collaborators (1)

GlaxoSmithKline

All Listed Sponsors

collaborator

GlaxoSmithKline

INDUSTRY

lead

Thomas Jefferson University

OTHER